Eva Colas

Dr. Eva Colás has been fully dedicated to endometrial cancer research during the last 12 years, with a special focus in the search of biomarkers to improve management of EC patients, although also investigating on the molecular basis of this disease and the development of new therapeutic approaches. From 2006 to 2014, she did her Ph.D. thesis and a first postdoctoral period in the Group of Biomedical Research in Gynecology at the Vall Hebron Research Institute. After a 2-year postdoc in the Group of Dr. Xavier Matias-Guiu (IRBLleida), she returned to the Group of Biomedical Research in Gynecology at VHIR and become principal researcher of the Endometrial Cancer Translational Research Line. During her PhD, she participated in the development of the diagnostic kit GynEC-DX®, in collaboration with Oryzon S.A. and Reig Jofre S.A. In the last years, Dr. Colás has lead the conception and development of a new molecular diagnosis of endometrial cancer, the CEMARK project, based on protein biomarkers analyzed in a sample of uterine fluid. The CEMARK project is now on the prototype development phase and is expected to reach the market in the next years.